Treatment Exposure and Discontinuation in the PALbociclib CoLlaborative Adjuvant Study of Palbociclib With Adjuvant Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer (PALLAS/AFT-05/ABCSG-42/BIG-14-03)
在帕博西尼联合辅助内分泌治疗激素受体阳性/人表皮生长因子受体 2 阴性早期乳腺癌的帕博西尼辅助治疗研究中,治疗暴露和停药情况 (PALLAS/AFT-05/ABCSG-42/BIG-14-03)
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.21.01918
Mayer, Erica L; Fesl, Christian; Hlauschek, Dominik; Garcia-Estevez, Laura; Burstein, Harold J; Zdenkowski, Nicholas; Wette, Viktor; Miller, Kathy D; Balic, Marija; Mayer, Ingrid A; Cameron, David; Winer, Eric P; Ponce Lorenzo, José Juan; Lake, Diana; Pristauz-Telsnigg, Gunda; Haddad, Tufia C; Shepherd, Lois; Iwata, Hiroji; Goetz, Matthew; Cardoso, Fatima; Traina, Tiffany A; Sabanathan, Dhanusha; Breitenstein, Urs; Ackerl, Kerstin; Metzger Filho, Otto; Zehetner, Karin; Solomon, Kadine; El-Abed, Sarra; Theall, Kathy Puyana; Lu, Dongrui Ray; Dueck, Amylou; Gnant, Michael; DeMichele, Angela
肿瘤
肿瘤免疫
信号转导
乳腺癌
BIG
Human
免疫/内分泌